-
Awarded10/07/2024
-
Today21/04/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Concentrate of activated prothrombin syndrome factor (aPCC) with delivery to Regional Blood Donation and Treatment Centers Text automatically translated in your browsing language Automatically translated
The subject of the contract is the delivery of activated prothrombin syndrome factor concentrate (aPCC) together with delivery to Regional Blood Donation and Treatment Centres together with a set for administration, in accordance with the description of the subject of the contract specified in the SWZ and under the conditions set out in the Draft Provisions of the Agreement (PPU), which are annexed to the SWZ. The purchase is carried out as part of the health policy programme of the Minister of Health entitled: ‘National Programme for the Treatment of Hemophilia and Related Hemorrhagic Infections 2024-2028’. Text automatically translated in your browsing language Automatically translated
33621000 - Medicinal products for the blood and blood-forming organs
33651000 - General anti-infectives for systemic use and vaccines CVP code deduced from the text of the procedure AI-generated
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents CVP code deduced from the text of the procedure AI-generated
Type: price
Description: Cena
Weight (percentage, exact): 60
Criterion:
Type: quality
Description: Serwis posprzedażny
Weight (percentage, exact): 40
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.